I never thought I’d see more people invest in marijuana than smoke it.

But those investments are exactly what’s about to happen given a recent survey from some of the most influential and social analysts in the BioPharma space. In fact, according to Investing.com and our research, two-thirds (2/3) of the analysts love the potential of the marijuana industry since the $50 Billion market is already developed, albeit illegal. The process of stepped legalization has started and continuing prospects look promising.

Yet there are dual dilemmas facing public medical marijuana companies in the United States. First, even if it’s legal for in-state cannabis companies, no businesses are federally legalized to sell the plant or the plant’s derivatives in any shape or form. Will the federal government’s tacit overlooking of the national cannabis laws continue?

Click here to read the entire article on Forbes.